| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | R Jeffrey Karnes | |
| Charles Y F Young | |||
| Krishna Vanaja Donkena | |||
| P2860 | cites work | Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression | Q21143876 |
| Vitamin C in human health and disease is still a mystery? An overview | Q21245913 | ||
| Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by beta-carotene through down-regulation of cyclin A and Bcl-2 family proteins | Q43833465 | ||
| Changes in diet, physical activity, and supplement use among adults diagnosed with cancer | Q44403833 | ||
| Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4. | Q44499112 | ||
| Mechanism of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells | Q44760274 | ||
| Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. | Q44767115 | ||
| Vitamin E supplements and risk of prostate cancer in U.S. men. | Q44790495 | ||
| Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study | Q45067083 | ||
| The singlet oxygen and carotenoid interaction | Q45187333 | ||
| Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. | Q46001274 | ||
| Dietary vitamins E and C and prostate cancer risk. | Q46006336 | ||
| One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. | Q46021239 | ||
| Intake of plant foods and associated nutrients in prostate cancer risk | Q46113402 | ||
| MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls. | Q46119303 | ||
| Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling | Q46163758 | ||
| Cohort study of diet, lifestyle, and prostate cancer in Adventist men. | Q46279489 | ||
| Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer | Q46320236 | ||
| A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer | Q46377734 | ||
| Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial | Q46413163 | ||
| Dietary folate and risk of prostate cancer in Italy | Q46432968 | ||
| Effect of retinoic acid on prostatic development | Q46438510 | ||
| The microarray expression analysis identifies BAX as a mediator of beta-carotene effects on apoptosis | Q46462880 | ||
| Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer | Q46518387 | ||
| Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study | Q46546383 | ||
| Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration? | Q46656672 | ||
| Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia | Q46847595 | ||
| Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. | Q46925833 | ||
| Lycopene and beta-carotene protect in vivo iron-induced oxidative stress damage in rat prostate. | Q46937660 | ||
| Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer | Q46954248 | ||
| Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. | Q46957678 | ||
| Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. | Q51505913 | ||
| The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer | Q24323885 | ||
| Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice | Q24644317 | ||
| Folic acid and risk of prostate cancer: results from a randomized clinical trial | Q24656971 | ||
| Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer | Q24670422 | ||
| Recent knowledge about intestinal absorption and cleavage of carotenoids | Q28240094 | ||
| Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs | Q28282070 | ||
| Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis | Q28290519 | ||
| Function of retinoic acid receptor gamma in the mouse | Q28507388 | ||
| Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 | ||
| Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. | Q30949867 | ||
| Modulation of genotoxic and related effects by carotenoids and vitamin A in experimental models: mechanistic issues | Q33608876 | ||
| Vitamin D and differentiation in cancer | Q33646179 | ||
| Cancer-preventive activities of tocopherols and tocotrienols | Q33814811 | ||
| Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis. | Q33864647 | ||
| Vitamin D deficiency and insufficiency among patients with prostate cancer | Q33927888 | ||
| Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer | Q33928521 | ||
| Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer | Q33956838 | ||
| Cancer incidence and mortality after treatment with folic acid and vitamin B12. | Q34020200 | ||
| Intake of carotenoids and retinol in relation to risk of prostate cancer | Q34288358 | ||
| Human prostate cancer risk factors | Q34360616 | ||
| Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer | Q34426763 | ||
| Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk | Q34494587 | ||
| A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. | Q34506565 | ||
| Folate, vitamin B12 and vitamin B6 and one carbon metabolism | Q34507048 | ||
| A prospective study of tomato products, lycopene, and prostate cancer risk | Q34521487 | ||
| Vitamin C and cancer revisited | Q34595214 | ||
| Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial | Q34601546 | ||
| Fruit, vegetable, vitamin A intakes, and prostate cancer risk | Q34630946 | ||
| Molecular basis of the potential of vitamin D to prevent cancer | Q34717856 | ||
| Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review | Q34743622 | ||
| Phase I clinical trial of i.v. ascorbic acid in advanced malignancy | Q34785845 | ||
| Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs | Q34842453 | ||
| Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. | Q53378586 | ||
| Vitamin D compounds: clinical development as cancer therapy and prevention agents. | Q53591466 | ||
| Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study | Q56988220 | ||
| UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States) | Q57095553 | ||
| Chemoprevention of prostate cancer | Q57141880 | ||
| Oxidation of carotenoids by free radicals: relationship between structure and reactivity | Q58487586 | ||
| Relationship Between Plasma Carotenoids and Prostate Cancer | Q60148920 | ||
| Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial | Q61773226 | ||
| Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma | Q73147203 | ||
| Vitamin and mineral supplement use is associated with reduced risk of prostate cancer | Q73148994 | ||
| Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States | Q73148998 | ||
| 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1 | Q73167155 | ||
| Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas | Q73388477 | ||
| A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice | Q73519160 | ||
| Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells | Q77312731 | ||
| Interaction of carotenoids and tocopherols with peroxynitrite | Q77908086 | ||
| Beta-carotene regulates NF-kappaB DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells | Q78882456 | ||
| Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer | Q79577858 | ||
| A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer | Q79738986 | ||
| Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators | Q79794482 | ||
| Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk | Q80173480 | ||
| A New Formulation of Calcitriol (DN-101) for High-Dose Pulse Administration in Prostate Cancer Therapy | Q80297729 | ||
| Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer | Q80370172 | ||
| Use of multivitamins and prostate cancer mortality in a large cohort of US men | Q80949076 | ||
| DNA methylation and cancer | Q81002014 | ||
| Estimating the cost of cancer care in the United States: a work very much in progress | Q81183914 | ||
| Vitamin D and prostate cancer risk--a less sunny outlook? | Q81343486 | ||
| Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study | Q81414780 | ||
| Chemoprevention of prostate cancer | Q82247059 | ||
| Folate nutrition and prostate cancer incidence in a large cohort of US men | Q82916158 | ||
| High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer | Q34979095 | ||
| The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. | Q35157811 | ||
| Modulation of transcriptional activity by antioxidant carotenoids | Q35571323 | ||
| Carotenoid radical chemistry and antioxidant/pro-oxidant properties. | Q35869682 | ||
| Lycopene: modes of action to promote prostate health | Q35869722 | ||
| Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma | Q35870666 | ||
| Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection | Q36037613 | ||
| Gene-nutrient interactions in one-carbon metabolism | Q36047985 | ||
| gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications | Q36083550 | ||
| Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol | Q36130067 | ||
| Bioactivity and protective effects of natural carotenoids | Q36159335 | ||
| Role of lycopene and tomato products in prostate health. | Q36159367 | ||
| Carotenoid actions and their relation to health and disease | Q36323052 | ||
| Dietary agents in the chemoprevention of prostate cancer | Q36340599 | ||
| Update on prostate cancer chemoprevention | Q36407211 | ||
| Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture | Q36422645 | ||
| Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice | Q36425851 | ||
| Natural and synthetic retinoids in prostate cancer. | Q36489314 | ||
| Multivitamin-multimineral supplements: who uses them? | Q36701918 | ||
| Serum vitamin D concentration and prostate cancer risk: a nested case-control study | Q36989937 | ||
| No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk | Q37103497 | ||
| Association between serum 25(OH)D and death from prostate cancer | Q37135234 | ||
| 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells | Q37165972 | ||
| Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) | Q37175475 | ||
| Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk | Q37175504 | ||
| Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial | Q37278586 | ||
| Vitamin D Receptor Genetic Polymorphisms and Prostate Cancer Risk: A Meta-analysis of 36 Published Studies | Q37285994 | ||
| Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort | Q37301131 | ||
| High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis | Q37321347 | ||
| Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial | Q37322524 | ||
| Vitamin D pathway gene variants and prostate cancer risk | Q37346115 | ||
| Vitamin D and prostate cancer risk: a review of the epidemiological literature | Q37435932 | ||
| Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival | Q37453789 | ||
| Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer | Q37463085 | ||
| Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk | Q37464517 | ||
| Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis | Q37586697 | ||
| Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies | Q37591920 | ||
| Expression of Fas ligand in activated T cells is regulated by c-Myc | Q38313969 | ||
| Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer. | Q38351611 | ||
| Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. | Q38445553 | ||
| Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects | Q39877967 | ||
| RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects | Q39899583 | ||
| High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor | Q39901668 | ||
| The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells | Q39960194 | ||
| ROS-triggered caspase 2 activation and feedback amplification loop in beta-carotene-induced apoptosis | Q40255407 | ||
| Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. | Q40365994 | ||
| The effect of beta-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1. | Q40411151 | ||
| Different effect of beta-carotene on proliferation of prostate cancer cells | Q40411157 | ||
| Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. | Q40473846 | ||
| c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway | Q40707744 | ||
| Protective effect of lycopene on lipid peroxidation and oxidative DNA damage in cell culture | Q40839691 | ||
| Introduction: the colorful, fascinating world of the carotenoids: important physiologic modulators | Q40928248 | ||
| Antioxidants in human health and disease | Q41138320 | ||
| Antagonism of androgen action in prostate tumor cells by retinoic acid | Q41456953 | ||
| Supplement use among men with prostate cancer | Q42661357 | ||
| Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) | Q42677963 | ||
| Mega-dose vitamin C as therapy for human cancer? | Q43233554 | ||
| Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review | Q43253832 | ||
| The analysis of the relationship between A1298C and C677T polymorphisms of the MTHFR gene with prostate cancer in Eskisehir population | Q43265111 | ||
| A phase II trial of calcitriol and naproxen in recurrent prostate cancer. | Q43295148 | ||
| Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. | Q43531395 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| prostate neoplasm | Q56014511 | ||
| P304 | page(s) | 1762-1783 | |
| P577 | publication date | 2010-03-12 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Vitamins and prostate cancer risk | |
| P478 | volume | 15 |
| Q34158269 | Laboratory medicine best practice guideline: vitamins a, e and the carotenoids in blood. |
| Q35049779 | Molecular mechanisms underlying the potentially adverse effects of folate |
| Q53144362 | Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. |
| Q37868753 | Prostate cancer and diet: food for thought? |
| Q38693824 | Recent advances in the determination of tocopherols in biological fluids: from sample pretreatment and liquid chromatography to clinical studies. |
| Q36845353 | The role of micronutrients in the risk of urinary tract cancer. |
Search more.